Pharmaceutical Manufacturing and Packaging of Omeprazole 20mg Capsules

The contract entails the manufacture, quality testing, and packaging of Omeprazole Extended-Release Capsules, 20mg, in blister packs, adhering strictly to National Stock Number and Defense Logistics Agency standards. The work must be performed at Fort Lewis, Washington, with all processes meeting required pharmaceutical and military specifications to ensure product integrity, consistency, and readiness for military medical use. The manufacturer is responsible for full compliance with all technical, quality control, and documentation requirements as defined by DLA protocols. This is a subcontract under NAICS code 325412, issued by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026. Although the solicitation number is not provided in the data, the official link directs to the DIBBS system where full details and submission instructions are available. There is no set-aside designation specified, and the contract is open to qualified subcontractors capable of meeting the stringent pharmaceutical and defense logistics criteria for this critical medication.